Search results
Results from the WOW.Com Content Network
Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), [10] [11] and immunoglobulin E-mediated food allergy. [12]
What you might pay for common pet medical conditions. Condition. Average cost. Prevalence. Skin conditions. $200 to $2,500 • Number 1 in dogs (32% of claims)
The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.
The symptoms are usually severe and can be fatal if not treated. It is most common in young adult dogs of any breed, but especially small dogs such as the Toy Poodle and Miniature Schnauzer. [6] Gallbladder mucocele is a disease whereby the gallbladder becomes extended with bile and mucus, which can lead to the blockage of bile outflow from the ...
Pet owners are facing longer wait times and rising costs at U.S. vet clinics. Some are taking their business to Mexico. Cheaper across the border: Why Americans are heading to Mexico for vet care
Cefovecin is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It is marketed by Zoetis under the trade name Convenia. It is used to treat skin infections caused by Pasteurella multocida in cats, and Staphylococcus intermedius and Streptococcus canis in dogs. The advantage of using a long ...
Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious ...
Deracoxib is a coxib class nonsteroidal anti-inflammatory drug (NSAID). [3] Like other NSAIDs, its effects are caused by inhibition of cyclooxygenase (COX) enzymes. [7] At the doses used to treat dogs, deracoxib causes greater inhibition of COX-2 than of COX-1, [3] but at doses twice those recommended for use in dogs, deracoxib significantly inhibits COX-1 as well.